This raises the question of the importance of increasing serum GLP-1 level versus ameliorating GLP-1 resistance, building on previous work showing short-term exercise programs to improve hepatic insulin extraction in patients with NAFLD [59]. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.